Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0000950170-25-005566

Options or other derivatives

  • President and CEO acquired 1,105,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Patel Sanjiv · President and CEO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-01-10 Grant or award : show line 1 in the form Stock Option (Right to Buy) +1,105,000 1,105,000 D
Loading xslF345X05/ownership.xml…